On July 11th, 2011, Aderans Research Institute, a biotechnology group specializing in non-surgical hair restoration, released an update on its (hair multiplication) clinical research.
During a recent hair loss conference in Paris, France, Aderans Chief Executive Officer Dr. Ken Washenik, MD, PhD gave a presentation on the Aderans hair multiplication process and the preliminary results from phase II of its clinical trials.
According to Dr. Washenik, during the “ARI process” follicular stem cells are extracted from the back of the scalp, cultivated for special multiplication in a laboratory, and injected into areas of balding scalp. Allegedly, this process greatly increases the number of viable hair follicles, which will grow and produce terminal hairs after injection into the recipient area.
Dr. Washenik continues by explaining that although it’s only preliminary, the data from the second phase of the clinical studies is promising and demonstrates a quantifiable level of new hair growth. Furthermore, Dr. Washenik states Aderans will continue improving its methods and hopefully someday achieve the consistency and success rates associated with traditional follicular unit extraction (FUE) and follicular unit transplantation (FUT) hair transplant surgery.
To review these hair cloning updates and watch Dr. Washenik’s presentation, please visit the following: Aderans Hair Cloning Updates.
Blake – aka Future_HT_Doc
Follow our community on Twitter
Watch hair transplant videos on YouTube
Technorati Tags: Aderans Research Institute, hair restoration, hair multiplication, hair loss, Aderans, ARI, follicular stem cells, balding, hair follicles, follicular unit extraction, FUE, follicular unit transplantation, FUT, hair transplant surgery, hair cloning, Aderans Hair Cloning